AbstractCheckpoint proteins are activated in response to genotoxic insults or replication stress to maintain genome integrity. Their function is believed to depend largely on the detection of the DNA damage or defects occurring during replication fork progression
AbstractGermline mutations of the human BRCA2 gene confer susceptibility to breast cancer. Although ...
SummaryBRCA1 has significant roles in DNA repair and cell cycle checkpoint control, and is important...
BRCA1 interacts with several proteins implicated in homologous and non homologous recombination and ...
EMSY is a novel gene encoding a protein that binds to the tumor suppressor BRCA2. EMSY maps to 11q1...
AbstractThe BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicat...
The BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicated in DN...
The BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicated in DN...
The BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicated in DN...
AbstractInherited mutations in BRCA1 or BRCA2 predispose to breast, ovarian, and other cancers. Thei...
AbstractIn this issue, Hughes-Davies et al. describe a novel gene product, EMSY, which suppresses th...
AbstractGermline mutations in BRCA1 confer a high risk of breast and ovarian tumors. The role of BRC...
Background: Male breast cancer (MBC) is a rare disease compared to female breast cancer (FBC). MBC s...
Breast cancer in one of the most common cancer worldwide. Among women this tumor accounts for over 2...
Mutations in breast cancer tumor susceptibility genes, BRCA1 and BRCA2, predispose women to early on...
Maintenance of genomic stability during DNA replication involves the cooperation of many genes and p...
AbstractGermline mutations of the human BRCA2 gene confer susceptibility to breast cancer. Although ...
SummaryBRCA1 has significant roles in DNA repair and cell cycle checkpoint control, and is important...
BRCA1 interacts with several proteins implicated in homologous and non homologous recombination and ...
EMSY is a novel gene encoding a protein that binds to the tumor suppressor BRCA2. EMSY maps to 11q1...
AbstractThe BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicat...
The BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicated in DN...
The BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicated in DN...
The BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicated in DN...
AbstractInherited mutations in BRCA1 or BRCA2 predispose to breast, ovarian, and other cancers. Thei...
AbstractIn this issue, Hughes-Davies et al. describe a novel gene product, EMSY, which suppresses th...
AbstractGermline mutations in BRCA1 confer a high risk of breast and ovarian tumors. The role of BRC...
Background: Male breast cancer (MBC) is a rare disease compared to female breast cancer (FBC). MBC s...
Breast cancer in one of the most common cancer worldwide. Among women this tumor accounts for over 2...
Mutations in breast cancer tumor susceptibility genes, BRCA1 and BRCA2, predispose women to early on...
Maintenance of genomic stability during DNA replication involves the cooperation of many genes and p...
AbstractGermline mutations of the human BRCA2 gene confer susceptibility to breast cancer. Although ...
SummaryBRCA1 has significant roles in DNA repair and cell cycle checkpoint control, and is important...
BRCA1 interacts with several proteins implicated in homologous and non homologous recombination and ...
DOI
Add to ORKG